Ying-Qiang Xiang, MD, PhD

Only 30% to 60% of patients with treatment-resistant schizophrenia benefit from clozapine monotherapy. Does augmentation with mood stabilizers/antiepileptics improve the chances of success? This meta-analysis of 22 randomized controlled...